University Health Network, Toronto: Lung Neoplasms trials
The registry lists 37 Lung Neoplasms studies with University Health Network, Toronto as lead sponsor. 9 are open to participants now and 1 have results posted.
Phase 1 5Phase 2 8No phase 24(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Lay Navigation Intervention for Patients With Lung CancerNot yet recruitingNCT07548788Not applicable
- Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)RecruitingNCT07524114
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Ex-Vivo COF Study for Lung Cancer ObservationEnrolling by invitationNCT04534413
- Talazoparib and Thoracic RT for ES-SCLCRecruitingNCT04170946Phase 1
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Ontario-wide Cancer TArgeted Nucleic Acid EvaluationRecruitingNCT02906943
- Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)RecruitingNCT01786590Not applicable
- Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung CancerRecruitingNCT01487603
- A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the LungCompletedNCT02185690Phase 1Results posted
- Margin Intraoperative CT Feedback Feedback StudyActive, not recruitingNCT07242053Not applicable
- A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWithdrawnNCT04262388Phase 2
- Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)TerminatedNCT03849950Not applicable
- Palliative Thoracic ImmunoRTActive, not recruitingNCT03705806
- Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary ResectionCompletedNCT03704870Phase 2
- Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive AssayCompletedNCT03558165
- PET CT Re-Planning NSCLC (4DCT-PET)CompletedNCT03403127Not applicable
- Phase II Lung Metcore - Preoperative Metformin for Lung CancerCompletedNCT03086733Phase 2
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsActive, not recruitingNCT02869217Phase 1
- Perfusion CT Imaging in Lung Cancer With SBRTCompletedNCT02755454Not applicable
- 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung CancerActive, not recruitingNCT02701699Not applicable
- Non-linear Multimodal Microendoscopy for Lung Cancer PathologyWithdrawnNCT02699229
- Cone-beam CT Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)CompletedNCT02496624Not applicable
- Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRTCompletedNCT02456246Not applicable
- EBUS/Spectrum AnalysisCompletedNCT01972386
- Self-Management Intervention for Breathlessness in Lung CancerCompletedNCT01585883Not applicable
- Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung CancerCompletedNCT01480973Not applicable
- Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2)CompletedNCT01337102Not applicable
- Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)CompletedNCT00462995Phase 2
- Endobronchial Ultrasound vs Mediastinoscopy in NSCLCCompletedNCT00372203Phase 2
- Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos WorkersCompletedNCT00188890
- Early Lung Cancer Detection Using Computed TomographyCompletedNCT00188734
- Computed Tomography (CT) in Head and Neck PatientsTerminatedNCT00188656Phase 1
- Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLCCompletedNCT00188617Phase 2
- Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung CarcinomaCompletedNCT00188279Phase 2
- CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- RadiotherapyCompletedNCT00188214Phase 2
- Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00052494Phase 1